The company based in Massachusetts(MA)reported a risein revenue to $30 milion for the year when compared to $2.69 million in the previous year.
A filing from the company with the Securities and Exchange Commission on Mar 9,2023 showed that its revenue is up 1016.49% year-over-year.
The company reported basic earnings per share of $55761386 and diluted earnings per share of $55761386.
Surface Oncology, Inc. operates in the
Biological Products, Except Diagnostic Substances sector.
Related News
